AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05377463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No Intervention Components
Description: Participants not assigned to components 1 and 2
Study NCT04421131 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pocket colposcope/Mobile phone camera
Description: The Pocket colposcope or mobile phone camera will be used to capture magnified digital images of the cervix
Study NCT04421131 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mIVAA
Description: A mobile-phone-based telemedicine platform that enables remote consultation with an expert colposcopist
Study NCT05063422 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: polymyxin b/trimethoprim ophthalmic, Carboxymethyl cellulose
Description: 3 forms of denture adhesives from each brands are used to compare the retentive strength on highly resorbed ridges
Study NCT04773340 — intervention group
Intervention type: BEHAVIORAL
Intervention: Dialectical Behavior Therapy
Description: Behaviorally-focused intervention for individuals with personality disorder and a history of significant behavioral problems.
Study NCT05660525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4 weeks of Nicotine lozenge
Description: All participants will receive at least 4 weeks of the NRT Patch. Some will be randomized to receive 4 weeks of lozenge in addition to the NRT Patch. NRT temporarily replaces nicotine from tobacco to reduce motivation to consume tobacco and nicotine withdrawal symptoms.
Study NCT05748483 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo for Atogepant
Description: Oral Tablet
Study NCT05748483 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topiramate
Description: Oral Capsule
Study NCT05748483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for Topiramate
Description: Oral Capsule
Study NCT05660525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 8 weeks of Nicotine Replacement Therapy Patch
Description: All participants will receive at least 4 weeks of the NRT Patch. Some will also be randomized to receive an additional 4 weeks of the NRT Patch
Study NCT05968664 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulator
Description: Spinal Cord Stimulator modified to deliver Time Variant Pulse (TVP) stimulation.
Study NCT05968664 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Cord Stimulator
Description: Spinal Cord Stimulator to deliver standard of care Time Invariant Pulse (TIP) stimulation.
Study NCT05660525 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: QuitAid
Description: All participants will receive at least 4 weeks of the NRT Patch. Some participants will also be randomized to receive the QuitAid intervention, based on a medication adherence intervention, addresses perceptions (e.g., motivation, self-efficacy, beliefs) and practicalities of using NRT (e.g., monitoring NRT use, establishing a reminder system). QuitAid includes 1 in-person session and 5 follow-up telephonic sessions with the participant's local pharmacist/technician.
Study NCT06188689 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pacing
Description: 1. Ventricular 10 beat burst at 500ms (120bpm)~2. Ventricular 10 beat burst at 400ms (150bpm)~3. Atrial 10 beat burst at 500ms (120bpm)~4. Atrial 10 beat burst at 400ms (150bpm).
Study NCT06636721 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LuCA Behavioral Intervention
Description: The intervention will integrate aspects of Cognitive Behavioral Therapy (identifying and challenging automatic thoughts, engaging in behavioral activation) and Acceptance and Commitment Therapy (integrating one's values, distancing skills). The intervention will include skills such as problem-solving, communicating with close others and the medical team, and breathing techniques to improve shortness of breath related to lung cancer.
Study NCT04962711 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heart Failure intervention (Cardio-Oncology Disease Management Plan (CO-DMP)
Description: A clinical review to ensure optimal risk factor control and cardioprotection along with exercise intervention.
Study NCT04962711 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: provided by participants' usual healthcare professional(s)
Study NCT05589701 — intervention group
Intervention type: RADIATION
Intervention: Radiotherapy
Description: Standard of care radiotherapy administered as per institutional guidelines.
Study NCT05981118 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Betamethasone dipropionate 0.05%
Description: 0.05% cream group will be treated once daily on both legs until clear or up to 12 weeks
Study NCT05981118 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tapinarof
Description: 1% tapinarof cream applied once daily to both legs until clear or up to 12 weeks
Study NCT04527549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib mesylate
Description: Given PO
Study NCT04527549 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dabrafenib mesylate
Description: Given PO
Study NCT04527549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Given PO
Study NCT04527549 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study NCT04527549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib dimethyl sulfoxide
Description: Given PO
Study NCT04527549 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trametinib dimethyl sulfoxide
Description: Given PO
Study NCT05440175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EMS, Mirror therapy & exercises
Description: EMS will be applied with frequency between 20-100 Hz and pulse width between 20 to 450us and Mirror therapy for 30 minutes and four days per week for a total duration of 12 weeks. Exercises include the flexion, extension of the wrist and elbow, ulnar and radial deviations , place any cylindrical object in patients palm and ask to lift the object off the table. other exercises includes external and internal rotations with different task orientations.
Study NCT05440175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CIMT & exercises
Description: Constraint induced movement therapy will be applied for 30 minutes and four days per week for a total duration of 12 weeks, it is a form of rehabilitation therapy that improves upper limb movement, it claims to improve the arm motor ability and the functional use of a paretic arm- hand. Exercises include the flexion, extension of the wrist and elbow, ulnar and radial deviations , place any cylindrical object in patients palm and ask to lift the object off the table. other exercises includes external and internal rotations with different task orientations.
Study NCT05440175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mirror therapy & exercises
Description: Mirror therapy will be given for 30 minutes and four days per week for a total duration of 12 weeks. The exercises include the flexion, extension of the wrist and elbow, ulnar and radial deviations , place any cylindrical object in patients palm and ask to lift the object off the table. other exercises includes external and internal rotations with different task orientations.
Study NCT05359354 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Personalized neoantigen tumor vaccine
Description: Biological: neoantigen tumor vaccine with or without PD-1 In dose escalation phase, subjects will receive neoantigen tumor vaccine only. In dose expansion phase, subjects will receive neoantigen tumor vaccine combination with PD-1
Study NCT05991947 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention measures are needed.
Study NCT06026124 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Retrieval-based word learning: Repeated Spaced Retrieval condition
Description: Each child will learn 8 novel nouns referring to unfamiliar plants and animals (nepp) and a related meaning (a nepp likes rain) in the context of a story book. Four of the nouns will be will be learned using repeated spaced retrieval. In this condition, they will initially hear the information and be asked to retrieve it. Thereafter, they will be asked to retrieve it after hearing 3 intervening words. After each retrieval attempt, they will hear the target information again. This procedure will occur on two consecutive days.
Study NCT06026124 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Retrieval-based word learning: Repeated Study condition
Description: Each child will learn 8 novel nouns referring to unfamiliar plants and animals (nepp) and a related meaning (a nepp likes rain) in the context of a story book. Four of the nouns will be will be learned using repeated study trials only (with no retrieval practice). In this condition, they will simply hear the information (word \& meaning) as part of the story. This procedure will occur on two consecutive days.
Study NCT06354972 — intervention group
Intervention type: PROCEDURE
Intervention: Minimally invasive surgical procedure
Description: All the experimental sites underwent a minimally-invasive surgical technique (MIST) procedure under magnification (Cortellini and Tonetti 2007). The full-thickness flap was minimally raised both on the buccal and oral side, avoiding vertical releasing incisions. Granulation tissue was scraped from the bony surfaces of the defect, and the root was debrided using minicurettes/ultrasonic device and chemically treated by EDTA. Regenerative procedure was carried out using a combination of enamel matrix derivatives and bone xenograft. The flaps were then repositioned and sutured in order to obtain passive primary closure.
Study NCT05660525 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smokefree TXT
Description: All participants will receive at least 4 weeks of the NRT Patch. Some participants will also be randomized to receive the SmokefreeTXT is a text-messaging program offered through the National Cancer Institute's Smokefree.gov initiative, which sends pre-programmed messages timed around a quit date. Participants will receive 3-5 messages a day for 7 weeks. The first week of messages focus on preparation and the remaining 6 weeks of messages focus on post-cessation strategies (e.g., relapse prevention), all timed relative to the quit date set at enrollment.
Study NCT05407844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) based palliative care
Description: Those in the intervention group will receive support from a dedicated CHW trained in motivational interviewing, components of palliative care communication, and social determinants of health.
Study NCT06416605 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Maxillary Alveolar Ridge Augmentation
Description: using tooth graft or bone graft to increase alveolar ridge width to be able to insert dental implant
Study NCT05779254 — intervention group
Intervention type: DRUG
Intervention: Neomycin Sulfate
Description: Postoperative day-1 Oral Antibiotic Prophylaxis + patients get po. 3x1000mg Neomycin sulfate and 3x500 mg Metronidazole
Study NCT06140823 — intervention group
Intervention type: OTHER
Intervention: Liver Risk Computation Model (LIRIC)
Description: A neural network model (LIRIC-NN) and a logistic regression model (LIRIC-LR) that use routinely collected EHR data to stratify individuals into HCC risk groups for the general population
Study NCT06140823 — intervention group
Intervention type: OTHER
Intervention: Liver Risk Computation Model (LIRIC)_cirrhosis
Description: A neural network model (LIRIC-NN) and a logistic regression model (LIRIC-LR) that use routinely collected EHR data to stratify individuals into HCC risk groups for the population with liver cirrhosis
Study NCT06140823 — intervention group
Intervention type: OTHER
Intervention: Liver Risk Computation Model (LIRIC)_no_cirrhosis
Description: neural network model (LIRIC-NN) and a logistic regression model (LIRIC-LR) that use routinely collected EHR data to stratify individuals into HCC risk groups for the population without liver cirrhosis
Study NCT05650437 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultraviolet Radiation
Description: The therapist cut three holes, each measuring 2 by 2 cm, into a piece of cardboard that was about 4 by 20 cm in size.The first hole was exposed for 90 seconds, the second for 60 seconds, and the third for 30 seconds
Study NCT05650437 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic exercise
Description: The postmenopausal women in groups (A and B) exercised on the treadmill; women should always warm up before beginning exercise and stop if they experience pain or shortness of breath. Each session lasted 30 minutes and included 5 minutes of warming up and 20 minutes of walking at 60% of their maximum heart rate (MHR). The maximum heart rate that the circulatory system can support during physical exercise is MHR=220. Three sessions a week for three months, followed by a five-minute cool-down
Study NCT05650437 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D supplementation
Description: Throughout three months, vitamin D supplements (800 IU) will be given to all postmenopausal women in both groups (A\&B)
Study NCT05660525 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tobacco Quitline
Description: All participants will receive at least 4 weeks of the NRT Patch. Some participants will also be randomized to receive a 4-session proactive tobacco quitline, with each session lasting 20-30 minutes and occurring on days 7, 14, 21 and 28.The quitline intervention incorporates 3 phases: (1) preparing to quit, (2) quitting process, and (3) relapse prevention.
Study NCT05660525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4 weeks of Nicotine Replacement Therapy Patch
Description: All participants will receive at least 4 weeks of the NRT Patch.
Study NCT05367934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch
Description: Therapeutic Touch for stress
Study NCT05367934 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Therapeutic Touch
Description: Therapeutic Touch for stress
Study NCT06538246 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blueprint
Description: This is a mobile app-based adaptive coping skills intervention that lasts 1 month
Study NCT06538246 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education program
Description: This is a mobile app-based education program that lasts 1 month
Study NCT05224128 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib 200mg
Description: Imatinib have to be taken 200mg/day orally for 24 weeks in a seated position with a meal or a large (at least 250 mL) glass of water
Study NCT05224128 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsules (similar appearance with imatinib) without active substance have to be taken orally for 24 weeks in a seated position with a meal or a large (at least 250 mL) glass of water
Study NCT05674864 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bifidobacterium Infants plus Enterococcus Feacium plus Lactobacillus Acidophilus
Description: Bifidobacterium Infants, Enterococcus Feacium, and Lactobacillus Acidophilus combination will be given as one capsule three times daily for 14 days
Study NCT05674864 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bifidobacterium Infants plus Enterococcus Feacium plus Lactobacillus Acidophilus
Description: Bifidobacterium Infants, Enterococcus Feacium, and Lactobacillus Acidophilus combination will be given as one capsule three times daily for 14 days
Study NCT04394572 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sample
Description: All patients included in the study will have blood sample
Study NCT05660525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 8 Weeks Nicotine Lozenge
Description: All participants will receive at least 4 weeks of the NRT Patch. Some will be randomized to receive 8 weeks of lozenge in addition to the NRT Patch. NRT temporarily replaces nicotine from tobacco to reduce motivation to consume tobacco and nicotine withdrawal symptoms.
Study NCT06626087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Prototype artificial intelligence algorithm
Description: Developed by the University of Hong Kong
Study NCT06626087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: LI-RADS
Description: The Liver Imaging Reporting and Data System (LIRADS) was established to standardize the lexicon, interpretation and communication of radiological findings related to HCC
Study NCT04336579 — intervention group
Intervention type: BEHAVIORAL
Intervention: Diaphragmatic Breathing
Description: Simple diaphragmatic breathing exercise
Study NCT06143683 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early Mobilization
Description: On post-operative day (POD) 1, active range of motion exercises of the elbow joint will be initiated under the observation and guidance of the physical therapy team. On POD 3, the patient will be transitioned to active as well as active-assisted range of motion exercises. The physical therapy team will provide an exercise sheet handout to patients (Appendix 5) and encourage patients to do the exercise for 10 repetitions, 2 times a day, holding each stretch for 30 seconds. On POD3, patients with non-meshed sheet hand grafts will undergo active range of motion exercises of the hands under the observation and guidance of the physical therapy team. On POD 5, the patient will be allowed to move the extremity as tolerated with no restrictions.
Study NCT06143683 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Late Mobilization
Description: Following surgery, the patient's grafted upper extremity will be immobilized using an elbow flexion blocking splint. From POD 1 to 4, the patient's affected extremity will be kept elevated and immobilized with a flexion blocking splint. On POD 5, the patient will be allowed to move the extremity as tolerated with no restrictions. The physical therapy team will guide the patient on POD5 through range of motion exercises, starting with active, then active assisted, then passive as tolerated.
Study NCT05537246 — intervention group
Intervention type: PROCEDURE
Intervention: PWV
Description: All cases were evaluated in the service before surgery. Pulse wave velocity measurement was performed with the MOBİL-O-GRAPH device, which is one of the noninvasive methods. Before measuring from patients; It was confirmed that there was no coffee/cigarette consumption within 30 minutes. After resting for 5 minutes in a quiet room, the cuff of the appropriate size was tied to the arm in such a way that it came to the brachial artery. The data recorded by the tonometer was transferred to the computer program. Care was taken that the patient did not move or talk during the measurement.
Study NCT05534282 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interaction-focused Music Therapy with Children and Significant Others (INMUT-KB) (exp. group)
Description: Interaction-focused music therapy with children with cancer and their significant others, delivered by trained music therapists.
Study NCT05534282 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Therapy with Children (MUT-K) (exp. group)
Description: Interaction-focused music therapy with children with cancer without the involvement of significant others, delivered by trained music therapists.
Study NCT05534282 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interaction-focused Music Therapy with Children and Significant Others (WG-KB) (control group)
Description: Study participants randomized to this group receive the intervention INMUT 10 weeks after the experimental groups.
Study NCT06272916 — intervention group
Intervention type: DRUG
Intervention: Aminophylline , magnesium sulphate and placebo
Description: Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section
Study NCT04064697 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valganciclovir
Description: The experimental intervention consists of taking the treatment Valganciclovir 900 mg morning and evening for 3 weeks
Study NCT06578299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inetetamab and Paclitaxel ± Pertuzumab
Description: Inetetamab and Paclitaxel ± Pertuzumab Inetetamab：was administered as an intravenous (IV) loading dose of 8mg/kg q3w on Day 1 of Cycle 1 (1 Cycle length = 21 days), and 6mg/kg q3w on Day 1 of subsequent cycles, until investigator-assessed radiographic or clinical progressive disease, unmanageable toxicity, or study termination.~Paclitaxel：Docetaxel 75mg/m2, albumin paclitaxel 260mg/m2, or paclitaxel liposomes 175mg/m2) is administered intravenously on the first day of every three weeks, until investigator-assessed radiographic or clinical progressive disease, unmanageable toxicity, or study termination.~Pertuzumab：was administered as an intravenous (IV) loading dose of 840mg q3w on Day 1 of Cycle 1 (1 Cycle length = 21 days), and 420mg q3w on Day 1 of subsequent cycles, until investigator-assessed radiographic or clinical progressive disease, unmanageable toxicity, or study termination.
Study NCT05981586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plyometric strengthening exercises
Description: Comparative effects 1
Study NCT05981586 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isotonic strengthening exercises
Description: Comparative effects 2